Dr. Druker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd, L952
Portland, OR 97239Phone+1 503-494-5596Fax+1 503-494-3688
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1984 - 1987
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1981 - 1984
University of California San Diego School of MedicineClass of 1981
Certifications & Licensure
OR State Medical License 1993 - 2025
WA State Medical License 2022 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Portland Monthly Magazine Castle Connolly, 2011
- Join now to see all
Clinical Trials
- A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL Start of enrollment: 2014 Apr 24
Publications & Presentations
PubMed
- 162 citationsA proteogenomic portrait of lung squamous cell carcinomaShankha Satpathy, Karsten Krug, Pierre M. Jean Beltran, Sara R. Savage, Francesca Petralia
Cell. 2021-08-05 - 235 citationsProteogenomic characterization of pancreatic ductal adenocarcinomaLiwei Cao, Chen Huang, Daniel Cui Zhou, Yingwei Hu, T. Mamie Lih
Cell. 2021-09-16 - 375 citationsProteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung AdenocarcinomaMichael A. Gillette, Shankha Satpathy, Song Cao, Saravana M. Dhanasekaran, Suhas Vasaikar
Cell. 2020-07-09
Journal Articles
- CRISPR-Cas9–Mediated Saturated Mutagenesis Screen Predicts Clinical Drug Resistance with Improved AccuracyRichard D Press, Brian J Druker, Michael R Green, Proceedings of the National Academy of Sciences
Press Mentions
OHSU Experts Elected to the National Academy of Medicine, One of the Highest Honors in the Fields of Health, MedicineOctober 21st, 2024- How Artificial Intelligence Is Aiding in Cancer ResearchSeptember 15th, 2024
- Internationally Renowned OHSU Cancer Biologist Elected to the National Academy of SciencesMay 2nd, 2023
- Join now to see all
Grant Support
- Chronic Myelogenous Leukemia And BCR-ABL SubstratesNational Cancer Institute2011–2012
- Senior LeadershipNational Cancer Institute2011
- Protocol Specific Research SupportNational Cancer Institute2011
- Protocol Review &Monitoring SystemNational Cancer Institute2011
- Proteomics Shared ResourceNational Cancer Institute2011
- Program Planning And EvaluationNational Cancer Institute2011
- Program LeadershipNational Cancer Institute2011
- Histapathology &Cancer Genotyping Shared ResourceNational Cancer Institute2011
- Flow Cytometry Shared ResourceNational Cancer Institute2011
- Developmental FundsNational Cancer Institute2011
- Data Safety Monitoring SystemsNational Cancer Institute2011
- Clinical Research Management Shared ResourceNational Cancer Institute2011
- Bioanalytical/Pharacokinetic Shared ResourceNational Cancer Institute2011
- AdministrationNational Cancer Institute2011
- Ohsu Knight Cancer InstituteNational Cancer Institute2009–2011
- Ohsu Knight Cancer Institute- Community Health Educator SupplementNational Cancer Institute2010
- Ohsu Knight Cancer Institute - Rapid SupplementNational Cancer Institute2010
- Accelerating Target Identification And Validation In Leukemia: Integrating Sirna-National Cancer Institute2009–2010
- Chronic Myelogenous Leukemia And BCR-ABL SubstratesNational Cancer Institute1995–2009
- Ohsu Cancer InstituteNational Cancer Institute2007–2008
- Cancer And KinasesNational Cancer Institute2005
- CBL Function In Cellular Signaling And TransformationNational Cancer Institute1999–2003
- Tyrosine Kinase Inhibitors As Antineoplastic AgentsNational Cancer Institute1999–2001
- Genetic Analysis Of The Activation Of A Tyrosine KinaseNational Cancer Institute1993–1994
- Genetic Analysis Of The Activation Of A Tyrosine KinaseNational Cancer Institute1990–1992
- Mutagenesis Of Polyoma Middle-T AntigenNational Cancer Institute1986
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
